Sarthi Pharma is a finished-dose manufacturer based in India. It appears in 8 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO) and ARCSA (EC). Its GMP standing is certified by CDSCO (India) and FDA (GH). Customs aggregates show $2.5M of exports covering 295 molecules to 12 destinations in 2025.
| Site | FDA FEI |
|---|---|
| mehsana, India | Not on file |
| tal bavlaahmedabad 382 220, India | Not on file |
| N.H.8A, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 5 | None |
| ARCSA (EC) | 3 | None |
| CDSCO (India) | None | 3 |
| FDA (GH) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $2.5M | 12 |
| 2024 | Not reported | $920K | 6 |
| 2023 | Not reported | $329K | 3 |
| 2022 | Not reported | $10K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Sarthi Pharma comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.